Pfizer Testing Oral Covid Treatment — Would Be First To Market

  • 📰 Forbes
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

After bringing the first vaccine to market, Pfizer hopes for the next breakthrough

a stage one clinical trial on an oral antiviral therapy that a Covid-19 patient could take when they first develop symptoms, which would make it the first oral antiviral treatment for coronavirus. ... [+]

Pfizer has been working with the company Biontech on the development of a Covid 19 vaccine. Photo: Christophe Gateau/dpa The trial is being conducted in the U.S. and relies on protease inhibitors—the same kind ofThe trial is randomized and includes placebo groups with both single and multiple-dose studies.

The company is also studying an intravenous antiviral to treat Covid-19, which is now being used on clinical trial patients hospitalized with Covid-19. “Together, the two [oral and intravenous antivirals] have the potential to create an end to end treatment paradigm that complements vaccination,” Pfizer chief scientific officer Mikael Dolsten said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in CA
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

carlquintanilla

Pfizer is on 🔥 pfizer_news

They just working the markets...

Canada Canada Latest News, Canada Canada Headlines